bamlanivimab/etesevimab (LY-CoV555/LY-CoV016) - Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/36823658
 
Feb 25, 2023
 
Prev Next